An undesired effect of preventive screening for cancer is often overlooked: it’s not only the tendency to diagnose more and more cancers that would be likely to grow slowly – and to increase overdiagnosis – but [more]
Male breast cancer is almost always oestrogen receptor positive, and is traditionally treated in line with guidelines for treating hormone-sensitive breast cancers in postmenopausal women. Ian Fentiman questions the rationale for this approach, pointing to [more]
For a disease that has led the field of molecular biology, it is surprising perhaps that so few biomarkers have been identified that can predict a person’s risk of developing cancer. Researchers are now looking [more]
“In the history of cancer research, there has always been tension between those who want to treat cancer and those who think we should prevent it,” writes the pioneering medical oncologist and former head of the [more]
Acute skin reactions associated with radiotherapy can be distressing and can lead to treatment interruption. Anticipating, assessing and managing the problem according to best evidence can make a big difference. Radiotherapy-related toxicity occurs because of [more]
Thrombosis is the second most common preventable cause of death in patients with cancer, so oncologists need to know how to identify who is at risk, and strategies for prevention and treatment. This overview presents [more]